Turn our CV experience into your competitive advantage

Cardiovascular research and development is one of the most diverse and complex therapeutic domains to navigate. Quintiles has brought together interventional and non-interventional cardiologists work side-by-side with our operational experts to optimize your CV trial through your product's lifecycle: from early-stage trials to pivotal trials for registration, to post-marketing surveillance.

banner_speciman collector

Quintiles has helped develop or commercialize 87% of the NMEs/BLA Cardiovascular products from 2004 to 2013.

Working with the right partner is critical as the incidence and prevalence of multiple cardiovascular indications

Better prepare yourself to meet the myriad of challenges of the most demanding therapeutic area patient recruitment, evolving regulatory landscapes, increasing competition from generics and payer scrutiny.

Take advantage of our global expertise

Greater insight to help improve your probability of success.

With our global reach and therapeutic breadth and depth, Quintiles has both clinical and operational expertise in cardiology and the capital required to drive your product’s success. In fact, Quintiles helped develop or commercialize all of the top 30 best-selling cardiovascular products or compounds.

You can take advantage of the know-how our team of over 2,750 has amassed working on more than 230 cardiovascular studies involving more than 340,200 patients and 37,000 investigator sites in 75 countries – in the past five years alone. And you’ll benefit from the long-term relationships we’ve built with academic key opinion leaders and investigators around the globe as they bring unmatched insight to your clinical development projects.

Rely on our comprehensive solution

Expertise at every stage.

Expertise at every stage.y on our comprehensive solution from early clinical development through late phase studies to commercialization. We can help maximize the potential of your therapy or cardiovascular device, while meeting critical time, quality and cost objectives. Our services include:
  • Protocol feasibility and site identification to help ensure on-target patient enrollment.
  • Regulatory strategy and execution and quality systems.
  • Accurate safety reporting to meet stakeholder demands in the US and abroad.
  • Cardiovascular device development, from catheters to combination products such as drug-eluting stents and in-vitro diagnostics.

The power of possibilities

Cardiovascular development presents some of the biggest challenges in pharmaceutical research. Quintiles has been at the forefront of those challenges – and been successful in helping sponsors overcome obstacles to achieve their goals.

Related Services

Early Clinical Development
Patient and Provider Engagement Services
Medical Device & Diagnostics